Liver cancer is the fifth most common cancer and the second leading cause of malignant
death in Asia, and Asia reports 72.5% of the world's cases in 2020. As the most common …

Globally, gastrointestinal cancers represent more than one-fourth of all cancer incidence
and one-third of cancer-related mortality. Although there has been much progress in …

Background & Aims Little is known about the natural course of nonalcoholic fatty liver
disease (NAFLD) with advanced fibrosis. We describe long-term outcomes and evaluate the …

Primary liver cancer, the majority of which are hepatocellular carcinomas, is now the second
leading cause of cancer death worldwide. Hepatocellular carcinoma is a unique cancer that …

The most recent version of the European Society for Medical Oncology (ESMO) Clinical
Practice Guidelines for the diagnosis, treatment and follow-up of hepatocellular carcinoma …

Primary liver cancer (namely hepatocellular carcinoma, HCC) is worldwide the fifth most
common cancer in men and the seventh one in women, and it represents the third most …

Despite several studies support a positive association between heavy alcohol consumption
and liver cancer risk, a consistent dose–risk relationship has not yet been established. We …

Hepatocellular carcinoma (HCC) is one of the most common malignancies leading to high
mortality rates in the general population; in cirrhotic patients, it is the primary cause of death …

Background and aims Hepatocellular carcinoma (HCC) is the sixth most common cancer
worldwide and its incidence has increased during the past decade. While hepatitis B and C …

The majority of hepatocellular carcinoma occurs over pre-existing chronic liver diseases that
share cirrhosis as an endpoint. In the last decade, a strong association between lifestyle and …